GlycoMimetics Inc. | Key People and Executives
Rachel K. King
President, Chief Executive Officer & Director
John L. Magnani
Director, Chief Scientific Officer & SVP-Research
Michael James Barrett
Chairman
Patricia S. Andrews
Independent Director
Scott E. Koenig
Independent Director
Daniel M. Junius
Independent Director
Mark Alan Goldberg
Independent Director
Timothy R. Pearson
Independent Director
Rachel K. King
President, Chief Executive Officer & Director
Brian M. Hahn
CFO, Secretary & Principal Accounting Officer
John L. Magnani
Director, Chief Scientific Officer & SVP-Research
Helen M. Thackray
Chief Medical Officer & SVP-Clinical Development
Henry Flanner
Vice President-Technical Operations
Armand Girard
Vice President-Corporate Development
Michael James Barrett
Chairman
Patricia S. Andrews
Independent Director
Scott E. Koenig
Independent Director
Daniel M. Junius
Independent Director
Mark Alan Goldberg
Independent Director
Timothy R. Pearson
Independent Director
| Address |
9708 Medical Center Drive
Rockville Maryland 20850
United States
|
|
Employees
|
- |
| Website |
http://www.glycomimetics.com |
| Updated |
07/08/2019 |
| GlycoMimetics, Inc. operates as a clinical stage biotechnology company, which focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. It develops proprietary glycomimetics that inhibit disease-related functions of carbohydrates. The company was founded by Rachel K. |
